121 related articles for article (PubMed ID: 3141845)
1. [Blood platelet changes in myeloproliferative disorders].
D'Angelo G; Calvano D; Giardini C
Minerva Med; 1988 Oct; 79(10):853-7. PubMed ID: 3141845
[TBL] [Abstract][Full Text] [Related]
2. Relation of platelet abnormalities to thrombosis and hemorrhage in chronic myeloproliferative disorders.
Wehmeier A; Südhoff T; Meierkord F
Semin Thromb Hemost; 1997; 23(4):391-402. PubMed ID: 9263357
[TBL] [Abstract][Full Text] [Related]
3. The paradox of platelet activation and impaired function: platelet-von Willebrand factor interactions, and the etiology of thrombotic and hemorrhagic manifestations in essential thrombocythemia and polycythemia vera.
Michiels JJ; Berneman Z; Schroyens W; Finazzi G; Budde U; van Vliet HH
Semin Thromb Hemost; 2006 Sep; 32(6):589-604. PubMed ID: 16977569
[TBL] [Abstract][Full Text] [Related]
4. Template bleeding time and clinical hemorrhage in myeloproliferative disease.
Murphy S; Davis JL; Walsh PN; Gardner FH
Arch Intern Med; 1978 Aug; 138(8):1251-3. PubMed ID: 277084
[TBL] [Abstract][Full Text] [Related]
5. Defective platelet beta-N-acetyl hexosaminidase content and release in chronic myeloproliferative disorders.
Emiliani C; Ciferri S; Mencarelli S; Mezzasoma AM; Momi S; Orlacchio A; Gresele P
Platelets; 2006 Feb; 17(1):20-9. PubMed ID: 16308183
[TBL] [Abstract][Full Text] [Related]
6. Bleeding time and platelet function in essential thrombocythemia and other myeloproliferative syndromes.
Finazzi G; Budde U; Michiels JJ
Leuk Lymphoma; 1996 Sep; 22 Suppl 1():71-8. PubMed ID: 8951775
[TBL] [Abstract][Full Text] [Related]
7. Biochemical and metabolic aspects of platelet dysfunction in chronic myeloproliferative disorders.
Pareti FI; Gugliotta L; Mannucci L; Guarini A; Mannucci PM
Thromb Haemost; 1982 Apr; 47(2):84-9. PubMed ID: 7101243
[TBL] [Abstract][Full Text] [Related]
8. Increased response to arachidonic acid and U-46619 and resistance to inhibitory prostaglandins in patients with chronic myeloproliferative disorders.
Cortelazzo S; Galli M; Castagna D; Viero P; de Gaetano G; Barbui T
Thromb Haemost; 1988 Feb; 59(1):73-6. PubMed ID: 3129810
[TBL] [Abstract][Full Text] [Related]
9. Simultaneous study of platelets and phagocytes in myeloproliferative disorders.
Laharrague PF; Corberand JX; Fillola G; Boneu BP; Pris JF
Biomed Pharmacother; 1984; 38(9-10):462-5. PubMed ID: 6597727
[TBL] [Abstract][Full Text] [Related]
10. Abnormal aggregation and increased size of platelets in myeloproliferative disorders.
Cortelazzo S; Barbui T; Bassan R; Dini E
Thromb Haemost; 1980 Jun; 43(2):127-30. PubMed ID: 7455970
[TBL] [Abstract][Full Text] [Related]
11. Platelet abnormalities in myeloproliferative disorders.
Holme S; Murphy S
Clin Lab Med; 1990 Dec; 10(4):873-88. PubMed ID: 2272179
[TBL] [Abstract][Full Text] [Related]
12. Platelet adhesion.
Packham MA; Mustard JF
Prog Hemost Thromb; 1984; 7():211-88. PubMed ID: 6397767
[TBL] [Abstract][Full Text] [Related]
13. Blood platelet calcium content and aggregation behaviour in myeloproliferative disorders and secondary thrombocytosis.
Mindner K; Ostermann G; Hochhaus A; Höche D; Till U
Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):461-4. PubMed ID: 2465953
[TBL] [Abstract][Full Text] [Related]
14. [Shortening of acetylsalicylic acid-prolonged bleeding time by means of desmopressin].
Beck KH; Bleckmann U; Mohr P; Kretschmer V; Huss B
Beitr Infusionsther Transfusionsmed; 1994; 32():437-9. PubMed ID: 9480140
[TBL] [Abstract][Full Text] [Related]
15. Platelet membrane fatty acids in thrombocytosis due to myeloproliferative disorders.
Leoncini G; Maresca M; Balestrero F; Benatti U; Armani U; Piana A
Cell Biochem Funct; 1984 Jan; 2(1):23-5. PubMed ID: 6467512
[TBL] [Abstract][Full Text] [Related]
16. Correlation between prolonged bleeding time and depletion of platelet dense granule ADP in patients with myelodysplastic and myeloproliferative disorders.
Malpass TW; Savage B; Hanson SR; Slichter SJ; Harker LA
J Lab Clin Med; 1984 Jun; 103(6):894-904. PubMed ID: 6233383
[TBL] [Abstract][Full Text] [Related]
17. Functionally thrombasthenic state in normal platelets following the administration of ticlopidine.
Di Minno G; Cerbone AM; Mattioli PL; Turco S; Iovine C; Mancini M
J Clin Invest; 1985 Feb; 75(2):328-38. PubMed ID: 3156146
[TBL] [Abstract][Full Text] [Related]
18. Platelet abnormalities in idiopathic myelofibrosis: functional, biochemical and immunomorphological correlations.
Leoni P; Rupoli S; Lai G; Brunelli MA; Belmonte MM; Pugnaloni A; Rabini RA; Mazzanti L; Biagini G
Haematologica; 1994; 79(1):29-39. PubMed ID: 15378946
[TBL] [Abstract][Full Text] [Related]
19. Pathobiology of animal platelets.
Meyers KM
Adv Vet Sci Comp Med; 1985; 30():131-65. PubMed ID: 3004158
[No Abstract] [Full Text] [Related]
20. Platelet unresponsiveness to collagen: involvement of glycoprotein Ia-IIa (alpha 2 beta 1 integrin) deficiency associated with a myeloproliferative disorder.
Handa M; Watanabe K; Kawai Y; Kamata T; Koyama T; Nagai H; Ikeda Y
Thromb Haemost; 1995 Mar; 73(3):521-8. PubMed ID: 7667837
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]